Shanghai Henlius Biotech, Inc. (2696.HK) announced that its self-developed innovative anti-PD-1 monoclonal antibody, HANSIZHUANG (serplulimab, Hetronifly® in Europe), in combination with chemotherapy ...
Under a new CEO and corporate name, Bettani Farms is seeking to capture a chunk of the North American alternative-cheese ...